ABL Texcell Diagnostics abandons Vela’s Singapore and US acquisition

Singapore’s diagnostics sector has lost a proposed ownership deal, with ABL Texcell Diagnostics abandoning its planned purchase of Vela’s local and US businesses.
The terminated non-binding letter of intent covered the entire share capital of Vela Operations Singapore and Vela Diagnostics USA. Its cancellation removes this route to an acquisition, leaving any replacement ownership proposal to be negotiated on its own terms.
The purchase was intended to extend ABL’s operational and commercial reach into Asia-Pacific and the United States. It followed an exclusive agreement to distribute Vela Diagnostics solutions in Europe, the Middle East and Africa, known as EMEA.
For ABL, the attraction was direct international reach alongside distribution. For Vela, the proposed combination offered a route to shared capabilities. The commercial task now is to preserve the value of cooperation without relying on integration under a new owner.
Distribution terms carry the immediate commercial weight
The original proposal required satisfactory due diligence, final agreements and a final determination of the transaction’s scope. Completion also depended on customary prerequisites and any necessary social, regulatory or stock exchange authorisations. These were substantial steps between an expression of interest and a completed purchase.
The letter created no obligation to complete the acquisition, apart from provisions expressly identified as binding. Commercial planning around such an agreement therefore carries execution risk until definitive terms are signed and the conditions are met.
For Singapore laboratory customers, ownership is useful chiefly through the commitments it supports. Product availability and technical support are the practical priorities. Singapore supply and service commitments would need to be defined separately from the reported EMEA agreement.
Funding also needs a precise commercial purpose. A payment to acquire shares and fresh capital for operations serve different needs. A future proposal would be more useful to customers and suppliers if it set out how investment in the business would accompany any ownership change.
For a replacement buyer, the appeal would depend on the business it could sustain after completion. Customer retention and the cost of maintaining support would shape the return. For a distribution partner, the priority is a workable allocation of sales and service responsibilities.
The next commercially decisive step is clarity from the parties on the EMEA distribution relationship and, separately, on Singapore supply and support arrangements. For Singapore customers, clarity on service commitments will carry more immediate weight than another preliminary acquisition proposal.

